nanotechnology | Science and Enterprise

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
about 20 hours ago
New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
about 20 hours ago
I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
about 2 days ago
Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
about 3 days ago
A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
about 3 days ago

Nanoscale Particles Deliver Crispr Cancer Treatments

By Alan, on November 19th, 2020%

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments

Blood Cells Transport Enzymes to Slow Cancer Spread

By Alan, on November 16th, 2020%

Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread

Start-Up Gains Drug Nanoparticle Manufacturing Tech

By Alan, on November 13th, 2020%

A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech

Flexible Device Attaches to Heart, Monitors Functions

By Alan, on November 4th, 2020%

Biomedical engineers designed a thin flexible implantable patch that attaches to the heart, monitors its functions, and can perform therapeutics. . . . → Read More: Flexible Device Attaches to Heart, Monitors Functions

Carb-X Funding Nanoscale Sponge to Treat Sepsis

By Alan, on October 21st, 2020%

A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis

Individual Cells Explored with Virtual Reality

By Alan, on October 13th, 2020%

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

Univ Lab, Company Developing Phone-Based Virus Sensor

By Alan, on September 22nd, 2020%

A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for detecting SARS-CoV-2 viruses by a smartphone camera. . . . → Read More: Univ Lab, Company Developing Phone-Based Virus Sensor

Small Biz Grant Funds Covid-19 Disinfectant Spray

By Alan, on September 10th, 2020%

A Florida start-up company is developing a fast-acting disinfectant spray that dries on contact, yet still kills Covid-19 viruses on surfaces. . . . → Read More: Small Biz Grant Funds Covid-19 Disinfectant Spray

Synthetic Antibodies Neutralize Covid-19 Virus Proteins

By Alan, on September 2nd, 2020%

A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses. . . . → Read More: Synthetic Antibodies Neutralize Covid-19 Virus Proteins

Vaccine Blocks Covid-19 Infections in Animal Tests

By Alan, on August 20th, 2020%

An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways. . . . → Read More: Vaccine Blocks Covid-19 Infections in Animal Tests

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise